-
1
-
-
85173331024
-
High-dose methylprednisolone for treatment of acute spinal cord injury
-
Young W, Xu ST, Gou SH. High-dose methylprednisolone for treatment of acute spinal cord injury. Zhongguo Jizhu Jisui Zazhi 2000;10(5):304-5
-
(2000)
Zhongguo Jizhu Jisui Zazhi
, vol.10
, Issue.5
, pp. 304-305
-
-
Young, W.1
Xu, S.T.2
Gou, S.H.3
-
2
-
-
85173315114
-
Curative effects of methylprednisolone on acute spinal cord injury and the existing problems
-
Sun TS. Curative effects of methylprednisolone on acute spinal cord injury and the existing problems. Zhongguo Jizhu Jisui Zazhi 2005;15(7):389-91
-
(2005)
Zhongguo Jizhu Jisui Zazhi
, vol.15
, Issue.7
, pp. 389-391
-
-
Sun, T.S.1
-
3
-
-
0034063626
-
Role of leukocytes in spinal cord injury in rats
-
Taoka Y, Okajima K. Role of leukocytes in spinal cord injury in rats. J Neurotranma 2000;17(3):219-29
-
(2000)
J Neurotranma
, vol.17
, Issue.3
, pp. 219-229
-
-
Taoka, Y.1
Okajima, K.2
-
4
-
-
0033756931
-
Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: A potential new anti-inflammatory treatment
-
Mabon PJ, Weaver LC, Dekaban GA. Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: a potential new anti-inflammatory treatment. Exp Neurol 2000;166(1):52-64
-
(2000)
Exp Neurol
, vol.166
, Issue.1
, pp. 52-64
-
-
Mabon, P.J.1
Weaver, L.C.2
Dekaban, G.A.3
-
5
-
-
0035144802
-
Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury
-
Xu J, Kim GM, Ahmed SH, et al. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J Neurosci 2001;21(1):92-7
-
(2001)
J Neurosci
, vol.21
, Issue.1
, pp. 92-97
-
-
Xu, J.1
Kim, G.M.2
Ahmed, S.H.3
-
6
-
-
18044387971
-
Methylprednisolone inhibits production of interleukin-1beta and interleukin-6 in the spinal cord following compression injury in rats
-
Fu ES, Saporta S. Methylprednisolone inhibits production of interleukin-1beta and interleukin-6 in the spinal cord following compression injury in rats. J Neurosurg Anesthesiol 2005;17(2):82-5
-
(2005)
J Neurosurg Anesthesiol
, vol.17
, Issue.2
, pp. 82-85
-
-
Fu, E.S.1
Saporta, S.2
-
7
-
-
0344838543
-
Pharyngolaryngeal lesions in patients undergoing cervical spine surgery through the anterior approach: Contribution of methylprednisolone
-
Pedram M, Castagnera L, Carat X, et al. Pharyngolaryngeal lesions in patients undergoing cervical spine surgery through the anterior approach: contribution of methylprednisolone. Eur Spine J 2003;12(1):84-90
-
(2003)
Eur Spine J
, vol.12
, Issue.1
, pp. 84-90
-
-
Pedram, M.1
Castagnera, L.2
Carat, X.3
-
8
-
-
85173395028
-
Methylprednisolone for treatment of acute spinal cord injury and study on preventive medication
-
Jia LS. Methylprednisolone for treatment of acute spinal cord injury and study on preventive medication. Zhongguo Jizhu Jisui Zazhi 2005;15(7):392-3
-
(2005)
Zhongguo Jizhu Jisui Zazhi
, vol.15
, Issue.7
, pp. 392-393
-
-
Jia, L.S.1
-
9
-
-
0035008462
-
Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-alpha production
-
Taoka Y, Okajima K, Uchiba M, et al. Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-alpha production. J Neurotranma 2001;18(5): 533-43
-
(2001)
J Neurotranma
, vol.18
, Issue.5
, pp. 533-543
-
-
Taoka, Y.1
Okajima, K.2
Uchiba, M.3
-
10
-
-
33846680373
-
The impact of methylprednisolone on lesion severity following spinal cord injury
-
Leypold BG, Flanders AE, Schwartz ED, et al. The impact of methylprednisolone on lesion severity following spinal cord injury. Spine 2007;32(3):373-8
-
(2007)
Spine
, vol.32
, Issue.3
, pp. 373-378
-
-
Leypold, B.G.1
Flanders, A.E.2
Schwartz, E.D.3
-
11
-
-
0043234140
-
Drug development in spinal cord injury: What is the FDA looking for?
-
Hall ED. Drug development in spinal cord injury: what is the FDA looking for? J Rehabil Res Dev 2003;40(4 Suppl 1): 81-91
-
(2003)
J Rehabil Res Dev
, vol.40
, Issue.4 SUPPL. 1
, pp. 81-91
-
-
Hall, E.D.1
-
12
-
-
33746573319
-
Methylprednisolone and other confounders to spinal cord injury clinical trials
-
Sipski ML, Pearse DD. Methylprednisolone and other confounders to spinal cord injury clinical trials. Nat Clin Pract Neurol 2006;2(8):402-3
-
(2006)
Nat Clin Pract Neurol
, vol.2
, Issue.8
, pp. 402-403
-
-
Sipski, M.L.1
Pearse, D.D.2
-
13
-
-
14844337850
-
Effects of methylprednisolone on the neural conduction of the motor evoked potentials in spinal cord injured rats
-
Lee BH, Lee KH, Yoon DH, et al. Effects of methylprednisolone on the neural conduction of the motor evoked potentials in spinal cord injured rats. J Korean Med Sci 2005;20(1):132-8
-
(2005)
J Korean Med Sci
, vol.20
, Issue.1
, pp. 132-138
-
-
Lee, B.H.1
Lee, K.H.2
Yoon, D.H.3
-
14
-
-
0035793955
-
Spinal taurine levels are increased 7 and 30 days following methylprednisolone treatment of spinal cord injury in rats
-
Benton RL, Ross CD, Miller KE. Spinal taurine levels are increased 7 and 30 days following methylprednisolone treatment of spinal cord injury in rats. Brain Res 2001; 893(1-2):292-300
-
(2001)
Brain Res
, vol.893
, Issue.1-2
, pp. 292-300
-
-
Benton, R.L.1
Ross, C.D.2
Miller, K.E.3
-
15
-
-
33746759560
-
Early administration of methylprednisolone decreases apoptotic cell death after spinal cord injury
-
Vaquero J, Zurita M, Oya S, et al. Early administration of methylprednisolone decreases apoptotic cell death after spinal cord injury. Histol Histopathol 2006;21(10):1091-102
-
(2006)
Histol Histopathol
, vol.21
, Issue.10
, pp. 1091-1102
-
-
Vaquero, J.1
Zurita, M.2
Oya, S.3
-
16
-
-
0034999442
-
Prostaglandin release by spinal cord injury mediates production of hydroxyl radical, malondialdehyde and cell death: A site of the neuroprotective action of methylprednisolone
-
Liu D, Li L, Augustus L. Prostaglandin release by spinal cord injury mediates production of hydroxyl radical, malondialdehyde and cell death: a site of the neuroprotective action of methylprednisolone. J Neurochem 2001;77(4): 1036-47
-
(2001)
J Neurochem
, vol.77
, Issue.4
, pp. 1036-1047
-
-
Liu, D.1
Li, L.2
Augustus, L.3
-
17
-
-
33845770262
-
Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center
-
Tsutsumi S, Ueta T, Shiba K, et al. Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine 2006;31(26): 2992-6
-
(2006)
Spine
, vol.31
, Issue.26
, pp. 2992-2996
-
-
Tsutsumi, S.1
Ueta, T.2
Shiba, K.3
-
18
-
-
0035893476
-
Methylprednisolone and acute spinal cord injury: An update of the randomized evidence
-
Bracken MB. Methylprednisolone and acute spinal cord injury: an update of the randomized evidence. Spine 2001;26(24 Suppl): S47-54
-
(2001)
Spine
, vol.26
, Issue.24 SUPPL.
-
-
Bracken, M.B.1
-
19
-
-
32244448891
-
End organ effects of high-dose human equivalent methylprednisolone in a spinal cord injury rat model
-
Kubeck JP, Merola A, Mathur S, et al. End organ effects of high-dose human equivalent methylprednisolone in a spinal cord injury rat model. Spine 2006;31(3):257-61
-
(2006)
Spine
, vol.31
, Issue.3
, pp. 257-261
-
-
Kubeck, J.P.1
Merola, A.2
Mathur, S.3
|